logo inserm fondateurCC UFRSMBH logoUSPN

2016

Scleroderma peripheral B lymphocytes secrete interleukin-6 and TGF-β and activate fibroblasts. Dumoitier N, Chaigne B, Régent A, Lofek S, Mhibik M, Dorfmüller P, Terrier B, London J, Bérezné A, Tamas N, Varin-Blank N, Mouthon L. Arthritis Rheumatol. 2016 Dec 19.

Biological processes in solar lentigo: insights brought by experimental models. Goorochurn R, Viennet C, Granger C, Fanian F, Varin-Blank N, Le Roy C, Humbert P. Exp Dermatol. 2016 Mar;25(3):174-7.

First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study. Meunier G, Ysebaert L, Nguyen-Thi PL, Lepretre S, Quinquenel A, Dupuis J, Lemal R, Aurran T, TomowiakC, Cymbalista F, Dilhuydy MS, Brion A, Morel P, Cazin B, Leblond V, Cartron G, Ré D, Béné MC, Michallet AS, Feugier P. Hematol Oncol. 2016 Nov 22.

Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells. Ah-Koon L, Lesage D, Lemadre E, Souissi I, Fagard R, Varin-Blank N, Fabre EE, Schischmanoff O. J Cell Mol Med. 2016 Oct;20(10):1956-65.

Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis. Denys A, Clavel G, Lemeiter D, Schischmanoff O, Boissier MC, Semerano L. J Cell Mol Med. 2016 May;20(5):855-63.

Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study. Thompson PA, Lévy V, Tam CS, Al Nawakil C, Goudot FX, Quinquenel A, Ysebaert L, Michallet AS,Dilhuydy MS, Van Den Neste E, Dupuis J, Keating MJ, Meune C, Cymbalista F. Br J Haematol. 2016 Nov;175(3):462-466.

Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphomaalways therapy related ? Bigenwald C, Harel S, Chevignon F, Roos-Weil D, Bernard OA, Amorim S, Brice P, Adès L, Nloga AM, Sébert M, Braun T, Eclache V, Thieblemont C, Fenaux P. Br J Haematol. 2016 Sep 23.

Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH). Nguyen-Khac F, Borie C, Callet-Bauchu E, Eclache V, Struski S. Ann Biol Clin (Paris). 2016 Oct 1;74(5):561-567.

Cytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH). Eclache V, Lafage-Pochitaloff M, Lefebvre C, Penther D, Raynaud S, Tigaud I. Ann Biol Clin (Paris). 2016 Oct 1;74(5):525-534.

Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH). Bilhou-Nabéra C, Bidet A, Eclache V, Lippert E, Mozziconacci MJ. Ann Biol Clin (Paris). 2016 Oct 1;74(5):517-523.

Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH). Nguyen-Khac F, Daudignon A, Eclache V, Lafage-Pochitaloff M, Lefebvre C, Luquet I, Penther D. Ann Biol Clin (Paris). 2016 Oct 1;74(5):509-510.

Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth. Schumacher Y, Aparicio T, Ourabah S, Baraille F, Martin A, Wind P, Dentin R, Postic C, Guilmeau S. Oncogene. 2016 May 19;35(20): 2602-14.

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper Tcell-derived lymphomas. Vallois D, Dobay MP, Morin RD, Lemonnier F, Missiaglia E, Juilland M, Iwaszkiewicz J, Fataccioli V, Bisig B, Roberti A, Grewal J, Bruneau J, Fabiani B, Martin A, Bonnet C, Michielin O, Jais JP, Figeac M, Bernard OA, Delorenzi M, Haioun C, Tournilhac O, Thome M, Gascoyne RD, Gaulard P, de Leval L. Blood. 2016 Sep 15;128(11):1490-502.

TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precedeevolution to complex karyotypes. Lazarian G, Tausch E, Eclache V, Sebaa A, Bianchi V, Letestu R, Collon JF, Lefebvre V, Gardano L, Varin-Blank N, Soussi T, Stilgenbauer S, Cymbalista F, Baran-Marszak F. Int J Cancer. 2016 Oct 15;139(8):1759-63.

Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy inchronic lymphocytic leukaemia. Saint-Georges S, Quettier M, Bouyaba M, Le Coquil S, Laurienté V, Guittat L, Lévy V, Ajchenbaum-Cymbalista F, Varin-Blank N, Le Roy C, Ledoux D. Oncotarget. 2016 Jul 5;7(27):41031-41046.

HBME-1 is expressed by erythroid precursors in early maturation stage and can be a valuable tool for evaluation of dyserythropoiesis in bone marrow core biopsy specimens. Arana R, Lusina D, Braun T, Letestu R, Gardin C, Martin A. J Clin Pathol. 2016 Oct;69(10):933-7.

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups. Gagez AL, Tuaillon E, Cezar R, Dartigeas C, Mahé B, Letestu R, Maisonneuve H, Gouilleux-Gruart V, Bollore K, Ferrant E, Aurran T, Feugier P, Leprêtre S, Cartron G. Blood Cancer J. 2016 Jan 22;6:e389.

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimalresidual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J, Palacio C, Stehlikova O,Kreuzer KA, Liptrot S, O'Brien D, de Tute RM, Marinov I, Hauwel M, Spacek M, Dobber J, Kater AP,Gambell P, Soosapilla A, Lozanski G, Brachtl G, Lin K, Boysen J, Hanson C, Jorgensen JL, Stetler-Stevenson M, Yuan C, Broome HE, Rassenti L, Craig F, Delgado J, Moreno C, Bosch F, Egle A, Doubek M,Pospisilova S, Mulligan S, Westerman D, Sanders CM, Emerson R, Robins HS, Kirsch I, Shanafelt T, PettittA, Kipps TJ, Wierda WG, Cymbalista F, Hallek M, Hillmen P, Montserrat E, Ghia P. Leukemia. 2016 Apr;30(4):929-36.

Multifaceted plasma membrane Ca(2+) pumps: From structure to intracellular Ca(2+) handling and cancer. Padányi R, Pászty K, Hegedűs L, Varga K, Papp B, Penniston JT, Enyedi Á. Biochim Biophys Acta. 2016 Jun;1863:1351-63.

Evaluation of Fluorescently Labeled Aerolysin as a New Kind of Reagent for Flow Cytometry Tests: Optimization of Use of FLAER, Hints, and Limits. Dahmani A, Roudot H, Cymbalista F, Letestu R. Am J Clin Pathol. 2016 Mar;145(3):407-17

Computerized ranking test in three French universities: Staff experience and students' feedback. Roux D, Meyer G, Cymbalista F, Bouaziz JD, Falgarone G, Tesniere A, Gervais J, Cariou A, Peffault deLatour R, Marat M, Moenaert E, Guebli T, Rodriguez O, Lefort A, Dreyfuss D, Hajage D, Ricard JD. Rev Med Interne. 2016 Mar;37(3):166-72.

Genetic profiling of CLL: a 'TP53 addict' perspective. Lodé L, Cymbalista F, Soussi T. Cell Death Dis. 2016 Jan 14;7:e2042


visuel asih